期刊
METABOLITES
卷 11, 期 4, 页码 -出版社
MDPI
DOI: 10.3390/metabo11040254
关键词
deprescribing; barriers; facilitators; older patients; benzodiazepines; Z-drugs; BZRA
资金
- Capital Region of Denmark
The use of benzodiazepines and Z-drugs in older patients is associated with increased risk of side effects, but deprescribing can help reduce inappropriate medication. Patients are more willing to deprescribe compared to physicians, with barriers identified among healthcare professionals like lack of knowledge and resistance from patients. Education is a key facilitator in successful deprescribing interventions.
Treatment of older patients with benzodiazepines and Z-drugs (BZRA) is associated with an increased risk of side effects. However, this treatment is still used among these patients. Deprescribing can be a tool to reduce inappropriate medication. This review aims to identify and compare barriers and facilitators of stakeholders involved in BZRA deprescribing in older patients and uncover potential gaps in the research field. The search was conducted in PubMed, EMBASE, PsycINFO, and Cochrane Library. Ten articles based on qualitative data on BZRA deprescribing in older patients (>= 65 years) published between 2005-2020 were included. Six articles referred to patients as stakeholders, two referred to physicians, and one to nurses and caregivers, respectively, indicating a need for more studies in the field. More barriers than facilitators were identified. Important findings were the patient willingness to deprescribe BZRA compared to physicians, who did not mention deprescribing to patients due to barriers such as expected patient resistance. Nurses mentioned barriers like lack of knowledge and the feeling that their options were not valued by physicians; education was found to be a shared deprescribing facilitator among the stakeholders. Being aware of deprescribing barriers and facilitators can be helpful in future successful deprescribing interventions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据